3 ASX stocks every Aussie investor should consider in 2026

These are my top picks!

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a subdued start to the year for ASX stocks. The S&P/ASX 300 Index (ASX: XKO) is 1.57% higher for the year-to-date, and the S&P/ASX 200 Index (ASX: XJO) is up 1.62% as cost-of-living pressures, cash rate hike concerns and market shifts weigh on investor sentiment.

In times like these, it's important for investors to see the forest through the trees and identify investment opportunities amid market ups and downs.

Here are three ASX stocks I think every Aussie investor should consider for their portfolio this year.

Three happy office workers cheer as they read about good financial news on a laptop.

Image source: Getty Images

Electro Optic Systems Holdings Ltd (ASX: EOS)

EOS is a red-hot Aussie defence stock that develops and produces advanced electro-optic technologies. For the year-to-date, the company's shares are down 8.44%, and while this isn't ideal, in the context of its enormous 646.72% annual gain, it's not too alarming.

The ASX stock has benefited from surging demand for exposure to the defence sector amid ongoing geopolitical volatility. Recent data shows that Global military spending reached an unprecedented US$2.7 trillion in 2024. I'd bet the figure was even higher for 2025.

The company has had several major contract wins recently and is well-positioned for strong growth this year. 

Analysts rate the shares a strong buy and tip an upside of up to 40.24% to $12.72 at the time of writing.

Telix Pharmaceuticals Ltd (ASX: TLX)

Telix shares are down 2.51% to $11.08 a piece for the year-to-date, at the time of writing. Thanks to several significant headwinds over the past year, they're now down 61.43% year-on-year.

Its recent Q4 FY25 results disappointed investors, despite the biotech stock reporting that it achieved its US$804 million FY25 guidance. Over the past few months, the company has also had regulatory filing issues with the US Food and Drug Administration.

But I think Telix still has exceptional growth potential amid a rapidly growing market, and at the current share price, in my view, the ASX stock is a buy.

Analysts mostly rate the shares as a strong buy and predict they could soar by up to 203.92% this year to $33.69 at the time of writing. 

BHP Group Ltd (ASX: BHP)

The mining giant recently took the reins as the largest stock on the Australian sharemarket. BHP shares crossed the $50 mark earlier this week, pushing the miner's market capitalisation to just over $253.5 billion. Commonwealth Bank of Australia (ASX: CBA) is now in second place, with a market capitalisation of around $251.9 billion.

At the time of writing, the miner's shares are down 0.85% to $50.17, although they're 9.65% higher for the year-to-date and 28.23% higher than this time last year.

Analysts' forecasts for the stock's direction from here are subdued, with most holding a neutral stance and some even expecting a slight downside. 

But unlike the two ASX stocks listed above, I think BHP shares should be considered this year for more than just the upside potential. It's worth noting that the company's production is growing, and the business is diverse and actively expanding. And, of course, the miner offers a strong passive income stream for investors seeking reliable cash flow. 

Over the past 12 months, BHP paid an interim dividend of 79.1 cents per share on 27 March and a final dividend of 91.9 cents per share on 25 September, both fully franked. That's a full-year passive income payout of $1.71 per share.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems and Telix Pharmaceuticals. The Motley Fool Australia has recommended BHP Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Warren Buffett
Exchange-Traded Funds (ETFs)

I think this Buffett-inspired ASX ETF is in the buy zone right now

This Buffett-inspired ETF is looking cheap.

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Opinions

Why I just invested $3,000 in these 3 ASX shares

These businesses have a lot to offer my portfolio. I bought them because...

Read more »

Rocket takes off from the hand of a businessman.
IPOs

What's gone wrong with the SpaceX IPO?

SpaceX rocketed on the IPO, but its flight path has since stalled.

Read more »

A female athlete in green spandex leaps from one cliff edge to another.
Opinions

A rare buying opportunity in 1 of Australia's top shares?

This stock could provide delicious returns.

Read more »

A graphic depicting a businessman in a business suit standing with his hand to his chin looking at a large red arrow pointing upwards above a line up of oil barrels againist the backdrop of a world map.
Energy Shares

With Hormuz closed, is there an opening to buy Woodside shares?

Should investors react to this news out of the Middle East?

Read more »

Three trophies in declining sizes with a red curtain backdrop.
Opinions

3 ASX shares I'd buy with $5,000 this week

These ASX shares are tipped to increase 20% or more over the next 12 months.

Read more »

A young investor working on his ASX shares portfolio on his laptop.
Opinions

2 ASX LICs to buy now: expert

LICs typically invest in diversified asset portfolios and are traded like ordinary ASX shares.

Read more »

A gold gloved hand is held up in a stop gesture.
Opinions

Up 80% in 2 years with a 15% dividend yield, expert says sell this ASX ETF now

Let's take a look.

Read more »